Background: Proteinuria is a major risk factor for the progression of kidney disease and the development of cardiovascular disease. Little is known, however, about risk factors for incident proteinuria.
jects with serum cholesterol levels of less than 200 mg/dL (Ͻ5.18 mmol/L), the adjusted RRs associated with serum cholesterol levels of 200 to 239 mg/dL (5.18-6.19 mmol/L) and 240 mg/dL or more (Ն6.22 mmol/L) were 1.13 (95% CI, 1.05-1.21) and 1.40 (95% CI, 1.27-1.54), respectively, in men and 1.14 (95% CI, 1.01-1.28) and 1.22 (95% CI, 1.00-1.37), respectively, in women. Persons with stages 1 and 2 hypertension had a greater adjusted RR of incident proteinuria compared with those with normal blood pressure (1.62 Conclusions: Fasting glucose and cholesterol levels, body mass index, and blood pressure were direct and independent predictors of incident proteinuria in Korean adults. These associations were present even at low levels of exposure, emphasizing the importance of early detection and management of these modifiable risk factors.
Arch Intern Med. 2005;165:2299-2304

P
ROTEINURIA IS A MAJOR INDEpendent risk factor for progression of chronic kidney disease (CKD) and development of cardiovascular disease (CVD). [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Little is known, however, about factors that determine the onset of proteinuria. Although hyperglycemia precedes the development of proteinuria among persons with types 1 and 2 diabetes mellitus, 16, 17 most studies demonstrating a relationship between proteinuria and CVD risk factors, including blood pressure, diabetes, cholesterol level, and smoking, are cross-sectional. [18] [19] [20] Hence, one cannot draw strong inferences about causality. Few studies have simultaneously assessed these and other potential predictors of incident proteinuria in the general population, 21, 22 despite the possibility that CVD and CKD are a result of common etiologic pathways.
In this setting, we assessed prospectively the relationship between CVD risk factors and incident proteinuria in a large cohort of 157 377 Korean adults free of proteinuria at baseline. 23 Of the 183 634 original study enrollees, the 26 257 (14.3%) with incomplete data at baseline on proteinuria or any of the CVD risk factors studied (blood pressure, serum cholesterol and fasting blood glucose levels, body mass index [BMI] , and smoking status) or with prevalent proteinuria were excluded, resulting in a final sample size of 157 377 (104 523 men and 52 854 women).
METHODS
STUDY POPULATION
DATA COLLECTION
In 1990, initial visits and physical examinations were conducted following a standardized protocol at 416 hospitals. Subsequently, biennial examinations were conducted. In 1992, participants returned for repeated laboratory measurements and were asked to describe their current levels of physical activity, smoking, alcohol consumption, treatment of hypertension and diabetes, and medical history. Information on treatment for hypercholesterolemia was not collected. The 1990 and 1992 biennial medical examinations included measurements of weight, height, fasting serum levels of glucose and total cholesterol, and semiquantitative dipstick testing of urine for protein. Alcohol use at baseline was assessed by the question, "Do you drink alcohol regularly?" Physical activity was assessed by the question, "Do you exercise regularly?"
Blood pressure was measured in the seated position using a mercury sphygmomanometer or automatic (oscillometric) manometer. In the case of manual manometers, systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured as the first and fifth Korotkoff sounds, respectively. Body mass index was calculated as the weight in kilograms divided by the square of height in meters.
Urine protein level was determined at each visit by results of a single urine dipstick semiquantitative analysis (NMultistix; Ames Division of Miles Laboratory Inc, Elkhart, Ind). Dipstick results of 1ϩ and 2ϩ corresponded to protein levels of about 300 and 1000 mg/L, respectively. Reported specificity was 97.4% and sensitivity was 46.0%. Rates of falsepositive findings were small (2.6%), whereas higher rates of falsenegative findings were present at urine protein levels of 200 to 1000 mg/L, resulting in the potential for underdiagnosis of proteinuria. 24 Dipstick urinalysis was performed on fresh, midstream urine samples collected in the morning. The results of the urine test were based on a color scale that quantified proteinuria as absent, trace, 1ϩ, 2ϩ, 3ϩ, and 4ϩ. Proteinuria was defined as a dipstick finding of 1ϩ or greater.
VISIT SCHEDULE
The percentages of participants who were examined at the 1994, 1996, 1998, and 2000-2002 biennial examinations were 95.7%, 94.3%, 92.0%, and 94.8%. Dipstick urinalysis was included at each follow-up visit. Among participants receiving an evaluation of urine protein level at baseline, 95.2% had at least 1 follow-up assessment of urine protein level, 87.9% had 2, 76.6% had 3, and 64.7% had 4.
POTENTIAL PREDICTORS OF PROTEINURIA
We considered participants to have diabetes if they had a fasting blood glucose level of 126 mg/dL or more (Ն7.0 mmol/L) or if they were taking medications for the treatment of diabetes. 25 We defined hypercholesterolemia according to the Na- 26 We categorized blood pressure level according to the guidelines of the Seventh Joint National Committee for the Detection, Evaluation, and Treatment of High Blood Pressure (normal, SBP of Ͻ120 and DBP of Ͻ80 mm Hg; prehypertension, SBP of 120-139 mm Hg or DBP of 80-89 mm Hg; stage 1 hypertension, SBP of 140-159 or DBP of 90-99 mm Hg; and stage 2 hypertension, SBP of Ն160 or DBP of Ն100 mm Hg). 27 To reduce measurement error, the mean of the values obtained in 1990 and 1992 was used for estimating baseline fasting blood glucose level, weight, height, total cholesterol level, and blood pressure. We classified participants as current smokers, ex-smokers, or nonsmokers. Assessments of these variables made at baseline were used in adjusted models.
STATISTICAL ANALYSIS
The primary outcome was a positive finding for proteinuria using a urine dipstick test at any of the 4 follow-up visits. We used Cox proportional hazards regression to ascertain the independent contribution of potential risk factors stratified by sex. We added all potential predictors of proteinuria into the Cox models simultaneously to assess the independent relationship with incident proteinuria. In our primary analysis, we used standard diagnostic criteria for each risk factor. In doseresponse analyses, we further divided risk factors (ie, BMI in 1-U increments, SBP in 10-mm-Hg increments, and fasting glucose in 10-mg/dL [0.6-mmol/L] increments). Age-adjusted incident proteinuria by BMI, total cholesterol level, SBP, and fasting blood glucose level were calculated to the age distribution of the 1995 South Korean national population. All analyses were stratified by sex. All analyses were conducted using SAS statistical software, version 8.0 (SAS Institute Inc, Cary, NC). A P value of less than .05 was considered statistically significant.
RESULTS
POPULATION CHARACTERISTICS
Baseline characteristics of the 157 377 persons are presented in Table 1 . The mean (SD) age was 45.0 (6.7) years in men and 42.5 (6.2) years in women. Among men and women, 4.3% and 1.2%, respectively, had diabetes; 8.5% and 6.7%, respectively, had a total cholesterol level of 240 mg/dL or more (Ն6.22 mmol/L); 27.5% and 10.2%, respectively, had hypertension; and 1.6% and 1.2%, respectively, reported treatment for hypertension. Cigarette smoking was highly prevalent in men (57.6%) but uncommon in women (0.4%).
INDEPENDENT PREDICTORS OF INCIDENT PROTEINURIA
During 10 years of follow-up, proteinuria developed in 3951 men (3.8%) and 1527 women (2.9%). Men and women with diabetes had relative risks (RRs) of incident proteinuria of 3.27 (95% confidence interval [CI], 2.98-3.58; PϽ.001) and 2.60 (95% CI, 1.98-3.43; PϽ.001), respec-tively, compared with participants without diabetes ( Table 2 ). In nondiabetic participants at baseline, the RR for incident proteinuria increased with increased fasting glucose level across ranges of glucose levels without an apparent threshold of increased risk ( The relation of fasting blood glucose level, BMI, total cholesterol level, and SBP with incident proteinuria was direct and progressive ( Figure) without an apparent threshold. Furthermore, increases in proteinuria incidence were present at levels below the standard clinical diagnostic criteria.
COMMENT
In this cohort study of middle-aged Korean adults, there were direct, progressive dose-response relationships of fasting blood glucose levels, BMI, total cholesterol level, and blood pressure with incident proteinuria. For fasting serum glucose level and BMI, statistically significant associations with incident proteinuria were evident at low levels of exposure. This observation is most striking for serum glucose level, for which increased risk occurs at levels of serum glucose well below those classified as diabetes based on current diagnostic criteria. [25] [26] [27] The presence of a threshold effect of serum glucose level on the progression of CKD has been debated in studies of persons with diabetes. Prospective observational studies have documented that diabetes and hypertension are major risk factors for progression of CKD and the incidence of end-stage renal disease. [28] [29] [30] However, few studies have examined longitudinal associations of serum glucose level and blood pressure with the development of incident proteinuria in general populations and at levels that are below the diagnostic thresholds (ie, SBP of Ͻ140 mm Hg or fasting serum glucose level of Յ125 mg/dL [Յ6.9 mmol/L]). Our data indicate that the incidence of proteinuria is not associated with conventional thresholds of serum glucose level or SBP that define diabetes or hypertension, but that it is associated with a progressive graded risk of proteinuria across levels of fasting serum glucose and blood pressure. [31] [32] [33] Cross-sectional and longitudinal data from large epidemiological studies support our findings of a positive association between BMI and proteinuria as well as an association between body fat distribution (ie, central fat distribution) and proteinuria. 22, 34 Proposed mechanisms for the relation between body fat and the presence or development of proteinuria include hyperinsulinemia causing direct glomerular damage or mediation through hyperglycemic effects on glomerular hemodynamics increasing glomerular pressure. 35, 36 Our findings of an association between serum cholesterol level and incident proteinuria are supported by cross-sectional and longitudinal studies demonstrating associations between lipid abnormalities and progressive CKD. Secondary analyses of statin trials provide indirect support. Specifically, some recent trials have demonstrated that statin therapy reduces urinary protein Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by the square of height in meters); DBP, diastolic blood pressure; KMIC, Korea Medical Insurance Corporation; SBP, systolic blood pressure.
SI conversion factors: To convert cholesterol to millimoles per liter, multiply by 0.0259; to convert glucose to millimoles per liter, multiply by 0.0555.
*Unless otherwise indicated, data are expressed as percentages. Percentages have been rounded and may not total 100. †For continuous variables, the mean values of the 1990 and 1992 visits were used as the baseline value.
excretion and slows progression of CKD. [37] [38] [39] Whether proteinuria reduction with statin therapy is due to reduction of lipid levels or the reported pleotrophic effects of statins is unknown.
The lack of association between smoking and proteinuria is somewhat surprising, given a preponderance of evidence implicating smoking as a major risk factor for the development of CVD outcomes. [40] [41] [42] [43] However, our findings are supported by a prospective epidemiological study in Japan. 22 Results of prior cross-sectional studies of the association between smoking and albuminuria among persons in the general population are inconsistent. 22, 44, 45 Body mass index appears to be an independent risk factor for incident proteinuria in this relatively lean population, despite adjustment for SBP, diabetes, and hypercholesterolemia. A direct effect of BMI on proteinuria, mediated through other mechanisms such as glomerular hyperfiltration, is plausible.
Our results extend existing evidence of a common link between CVD risk factors and incident proteinuria and provide additional strong evidence in support of early identification and appropriate management of these risk factors. [46] [47] [48] Our findings regarding incidence of proteinuria at low levels of fasting serum glucose, BMI, total cholesterol, and blood pressure suggest that attainment of lower goals for these clinical measures might have a substantial impact on the incidence of proteinuria.
Limitations of this analysis deserve mention. First, dipstick urinalysis has imperfect sensitivity and specificity, particularly in women and older persons, in whom the number of false-positive results can be high owing to menstruation or comorbid illness. 49 Second, the body habitus and dietary patterns of Korean adults differ from those of Western populations, potentially affecting the distribution of risk factors and the magnitude of risk relationships. Still, as for other chronic diseases, risk relationships tend to be similar even if absolute risks differ across populations. 50 Notwithstanding these limitations, our study finding that CVD risk factors are prospectively associated with incident proteinuria is consistent with the hypothesis that common pathways underlie the pathogenesis of CVD and proteinuria and early manifestation of kidney disease.
CONCLUSIONS
Results from the KMIC study document that fasting blood glucose level, BMI, cholesterol level, and blood pressure in men and women are independent predictors of incident proteinuria. Furthermore, risk increases in a progressive, dose-response manner at levels below currently accepted clinical risk factor thresholds for the prevention of CVD. Early detection and management of these modifiable risk factors may prevent CVD and proteinuria, a risk factor for kidney disease. 
